Help
FL regimen: Difference between revisions
Jump to navigation
Jump to search
Visual
Wikitext
Revision as of 20:05, 30 March 2015
(
view source
)
Aparna Vuppala
(
talk
|
contribs
)
No edit summary
← Older edit
Revision as of 20:11, 30 March 2015
(
view source
)
Aparna Vuppala
(
talk
|
contribs
)
(Blanked the page)
Newer edit →
Line 1:
Line 1:
__NOTOC__
{{SI}}
{{CMG}}; {{AE}} {{AV}}
==Overview==
{{PAGENAME}} refers to a regimen consisting of [[fludarabine]] , [[amsacrine]] , and [[ara-c]] used to treat xxx.<ref name="pmid21963618">{{cite journal| author=Saure C, Schroeder T, Zohren F, Groten A, Bruns I, Czibere A et al.| title=Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. | journal=Biol Blood Marrow Transplant | year= 2012 | volume= 18 | issue= 3 | pages= 466-72 | pmid=21963618 | doi=10.1016/j.bbmt.2011.09.006 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21963618 }} </ref>
==Regimen==
{{chemo|FL|Fludarabine}}
{{chemo|AMS|Amsacrine}}
{{chemo|A|Ara-c}}
==Indications==
==References==
{{Reflist|2}}
[[Category:Chemotherapy regimens]]
Revision as of 20:11, 30 March 2015
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
OK
Navigation menu
Personal tools
Log in
Request account
Namespaces
Home
Page
Discussion
English
Views
Read
View source
View history
Help
More
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information